Medications for Managing Nausea During Opiate Withdrawal
For managing nausea during opiate withdrawal, first-line treatment includes prochlorperazine 10 mg PO every 6 hours as needed, thiethylperazine 10 mg PO every 6 hours as needed, or haloperidol 0.5-1 mg PO every 6-8 hours. 1
First-Line Antiemetic Options
- Prochlorperazine 10 mg PO every 6 hours as needed is an effective first-line agent for opiate withdrawal-induced nausea 1
- Thiethylperazine 10 mg PO every 6 hours as needed can be used as an alternative phenothiazine 1
- Haloperidol 0.5-1 mg PO every 6-8 hours is another effective option, particularly if the patient has concurrent agitation 1
- For patients with a prior history of opioid-induced nausea, prophylactic treatment with antiemetic agents is highly recommended 1
Treatment Algorithm for Persistent Nausea
If nausea persists despite as-needed regimen:
- Administer antiemetics around the clock for 1 week, then change to as-needed dosing 1
- Consider adding metoclopramide 10-20 mg PO three times daily, which has both central and peripheral effects 1
- If nausea continues, add a serotonin antagonist such as ondansetron 1:
Special Considerations
- For patients with severe nausea, intravenous ondansetron 8 mg has shown efficacy with 62.3% complete control of emesis compared to 45.7% with placebo 3
- Consider adding dexamethasone if nausea persists for more than a week 1
- Promethazine 12.5-25 mg PO every 6 hours can be used if pruritus accompanies nausea during withdrawal 1
Combination Therapy Approach
- When managing persistent opioid-induced nausea, adding therapies that target different mechanisms of action may produce synergistic effects 1
- Consider combining a dopamine antagonist (prochlorperazine) with a serotonin antagonist (ondansetron) for refractory cases 1
- Prochlorperazine 5 mg administered with oxycodone has shown an 18.1% incidence of nausea in opioid-naïve patients 4
Important Caveats and Pitfalls
- Always assess for other causes of nausea (e.g., constipation, CNS pathology, hypercalcemia) before attributing symptoms solely to withdrawal 1
- Long-term administration of anti-dopaminergic agents may cause extrapyramidal symptoms 5
- Serotonin antagonists can cause constipation as a side effect, which may worsen overall withdrawal symptoms 1
- While ondansetron has shown promise for nausea control, it may not directly reduce other withdrawal symptoms 6, 7
- Female patients may be at higher risk for opioid-induced nausea and may require more aggressive antiemetic therapy 4
Monitoring and Follow-up
- Reassess cause and severity of nausea if symptoms persist despite treatment 1
- If multiple antiemetics fail, consider opioid rotation to a different opioid with potentially less emetogenic effects 1
- For patients with severe, intractable nausea during withdrawal, consider neuraxial analgesics or neuroablative techniques to potentially reduce the opioid dose 1